International Clinical Trial: Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07811271) titled 'Efficacy and Safety of BG-C9074 With Bevacizumab Compared With Bevacizumab in Adults With Ovarian, Fallopian Tube, or Primary Peritoneal Cancers' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: BeOne Medicines

Condition: Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Intervention: Drug: BG-C9074

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 2026

Target Sample Size: 600

To know more, visit https://...